Skip to main content

Science — Portfolio, Page 20

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

4,105
Companies
$204.3M
Total invested
$5.8M
Avg. check
44
Industries
Biotechnology 12Health Care 9Medical 7Chemical 3Manufacturing 3Therapeutics 3+38 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 457–480 of 4,105
AirOmatix
June 2022

AirOmatix is an NSF-funded developer of a novel, patent-pending technology for concentrating and removing oxygen from air.

Chemical · Portland$50K Pre-Seed
Zymosense
June 2022

Zymosense develops novel probes for onsite and throughput enzyme measurement.

Biotechnology · AmesGrant
NanoSpy, Inc.
June 2022

Rapid detection biosensor; collection to detection in 20 minutes.

Biotechnology · AmesGrant
Wondr Medical
June 2022

Wondr Medical is the platform for medical discovery, built around health care professionals.

Health Care · London$14.6M Seed
Photonect Interconnect Solutions
June 2025

Photonect Interconnect Solutions is a company that provides design services to make photonic connections more power-efficient.

Manufacturing · Rochester$1.3M Grant
Max-IR Labs
June 2022

Max-IR Labs develops infrared chemical and thermal sensor technology for defence-related products.

Chemical · Dallas$260K Grant
Decoy Therapeutics
June 2026

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Biotechnology · Cambridge$3.5M Post-IPO Equity
Oncorena
June 2025

Oncorena treatment for renal cancer

Biotechnology · Lund$14.0M Venture - Series Unknown
Thermalytica
June 2024

Thermalytica manufactures, researches, develops, markets, and advises on heat-insulating and heat-shielding materials.

Advanced Materials · Tsukuba$50K Grant
Acer Therapeutics
June 2023

Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.

Biotechnology · Newton$1.0M Post-IPO Debt
Covatic
June 2026

Covatic is the use of mobile based algorithms to bring smart personalisation to apps.

Advertising · Birmingham$2.0M Series B
Optimeos Life Sciences
June 2026

Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to treat diseases.

Biotechnology · PrincetonVenture - Series Unknown
eXoZymes
June 2026

eXoZymes develops enzyme-based biomanufacturing solutions that use AI-enhanced, cell-free enzyme systems.

Artificial Intelligence (AI) · Monrovia$2.0M Grant
RQ Bio
June 2026

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

Biotechnology · London$112.5M Series A
28bio
June 2025

28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.

Biopharma · Metairie$6.5M Undisclosed
Vico Therapeutics
June 2024

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Health Care · Leiden$12.3M Series B
Qubic Technologies
June 2026

Qubic Technologies is a manufacturer of quantum microwave transmitters and receivers for remote sensing and communication.

Cloud Computing · Quebec$2.5M Seed
REEcycle
June 2025

REEcycle is a Houston based company reclaiming materials known as rare earth elements from recycled electronics.

Recycling · HoustonVenture - Series Unknown
Plant Health Care
June 2023

Plant Health Care is a leading provider of scientifically proven biological products for the agricultural industry.

Agriculture · Raleigh$3.6M Post-IPO Equity
BibliU
June 2026

BibliU provides colleges and universities with digital content management, automation, and an analytics platform.

E-Learning · London$55.0M Private Equity
Hexigone Inhibitors
June 2026

Hexigone is an agile and progressive pigment company that works with multi-nationals to provide environmentally responsive coatings.

Chemical · Wales$1.6M Seed
Imperative Care
March 2026

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Health Care · Campbell$100.0M Convertible Note
Rubi Laboratories
March 2026

Rubi Laboratories develops biocatalyst solutions that turn carbon emissions into carbon-negative textiles.

Biotechnology · San Francisco$7.5M Series Unknown
Ternary Therapeutics
March 2026

Ternary Therapeutics is a biotechnology research center that specializes in bioinformatics and medicinal chemistry services.

Analytics · London$4.8M Seed

Where Science invests

Biotechnology12
Health Care9
Medical7
Chemical3
Manufacturing3
Therapeutics3

About Science's portfolio

How many companies has Science invested in?▸

Science has invested in 4,105 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Science invest in?▸

Science's top investment sectors include Biotechnology, Health Care, Medical, Chemical, Manufacturing. The firm invests across 44 different industry categories.

What is Science's largest investment?▸

Among tracked funding rounds, RQ Bio received $112.5M in a Series A round. Science's total known invested capital is $204.3M.

What is the average investment size for Science?▸

Science's average investment size is $5.8M across its portfolio of 4,105 companies.

What are Science's most recent investments?▸

Recent Science portfolio additions include AirOmatix, Zymosense, NanoSpy, Inc., Wondr Medical, Photonect Interconnect Solutions. These companies were founded in 2020 or later.

Reach the founders behind these 4,105 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →